{"id":"W1925087877","doi":"10.1111/j.1468-3083.2011.04332.x","title":"Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Welichem Biotech (Canada); Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Randomized controlled trial; Adverse effect; Psoriasis Area and Severity Index; Body surface area; Clinical endpoint; Internal medicine; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009116153,0.0002343652,0.001550419,0.0002297662,0.0001180144,0.00000278547,0.0003160835,0.0003006377,0.00002220078],"category_scores_gemma":[0.0002670146,0.0001349901,0.000173141,0.0001047048,0.0005674682,0.00007168663,0.0001732026,0.0004230824,0.000002841051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001111812,"about_ca_system_score_gemma":0.00003945028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001769291,"about_ca_topic_score_gemma":0.000007069376,"domain_scores_codex":[0.9953916,0.002705381,0.001348371,0.0002458451,0.00005801595,0.0002507844],"domain_scores_gemma":[0.9979108,0.0007534309,0.001071382,0.0001480417,0.00005955619,0.00005676379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9873412,0.0008941414,0.00543382,0.000007304899,0.001281769,0.00001824062,0.002042493,0.000008304319,0.0005017089,0.0003805566,0.00008933446,0.002001108],"study_design_scores_gemma":[0.9692419,0.0008135125,0.02265101,0.00009430583,0.0007820232,0.000153835,0.00004656317,0.000003384859,0.005667023,0.0002324028,0.0001858828,0.0001281676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958957,0.001187308,0.00003506123,0.0008341011,0.0003965025,0.0009166978,0.00003454972,0.000004939994,0.0006951501],"genre_scores_gemma":[0.9992455,0.0002398702,0.000230922,0.0001129631,0.00005535423,0.00000803383,0.000007766609,0.00001333198,0.00008621281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01809933,"threshold_uncertainty_score":0.5504739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03312076175434684,"score_gpt":0.264419496675059,"score_spread":0.2312987349207122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}